- Previous Close
699.10 - Open
715.60 - Bid 672.00 x --
- Ask 711.60 x --
- Day's Range
690.80 - 722.00 - 52 Week Range
690.80 - 959.00 - Volume
75,195 - Avg. Volume
29,376 - Market Cap (intraday)
161.229B - Beta (5Y Monthly) 0.26
- PE Ratio (TTM)
30.99 - EPS (TTM)
22.50 - Earnings Date May 6, 2025
- Forward Dividend & Yield 20.00 (2.76%)
- Ex-Dividend Date May 15, 2023
- 1y Target Est
--
Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
www.coloplast.com14,700
Full Time Employees
September 30
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: 0QBO.IL
View MorePerformance Overview: 0QBO.IL
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0QBO.IL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0QBO.IL
View MoreValuation Measures
Market Cap
156.27B
Enterprise Value
180.12B
Trailing P/E
32.13
Forward P/E
26.74
PEG Ratio (5yr expected)
2.36
Price/Sales (ttm)
5.72
Price/Book (mrq)
10.16
Enterprise Value/Revenue
6.56
Enterprise Value/EBITDA
20.60
Financial Highlights
Profitability and Income Statement
Profit Margin
19.66%
Return on Assets (ttm)
12.40%
Return on Equity (ttm)
69.51%
Revenue (ttm)
24.33B
Net Income Avi to Common (ttm)
4.78B
Diluted EPS (ttm)
22.50
Balance Sheet and Cash Flow
Total Cash (mrq)
855M
Total Debt/Equity (mrq)
340.76%
Levered Free Cash Flow (ttm)
2.74B